title: Oxygen radicals and antioxidant enzymes alter pulmonary vascular reactivity in the rat lung.
abstract: It has been postulated that changes in the availability of partially reduced O2 species, such as O2 radicals, could serve as a link between PO2 in the alveolus and pulmonary vascular tone (Herz 11: 127-141, 1986). To assess this hypothesis, the hemodynamic effects of acute changes in the balance between the production of O2 radicals and availability of antioxidant enzymes were studied in the isolated perfused rat lung. Intravascular generation of O2 radicals, by administration of xanthine-xanthine oxidase, decreased the pulmonary vascular pressor response to alveolar hypoxia (-55 +/- 5%) and angiotensin II (-58 +/- 10%, P less than 0.01 for each) in isolated perfused rat lungs without increasing the lung wet-to-dry weight ratio. Decreases in pulmonary vascular reactivity were inhibited by pretreatment of the lung with desferrioxamine or a mixture of catalase and superoxide dismutase. Catalase and superoxide dismutase preserved the hypoxic pressor response whether given in liposomes or in dissolved form. Superoxide dismutase administered free in solution, or combined with catalase in liposomes, increased the normoxic pulmonary arterial pressure and enhanced vascular reactivity to angiotensin II and hypoxia. Lungs treated with antioxidant enzymes in liposomes had 50% higher lung catalase levels than control lungs (P less than 0.05). These findings demonstrate that exogenous partially reduced O2 species can decrease pulmonary vascular reactivity and suggest that endogenous radicals, superoxide radical in particular, might be important in modulating pulmonary vascular tone.
authors.affiliation: Department of Medicine, Veterans Administration Medical Center, Minneapolis, Minnesota 55455.
authors.forename: S L
authors.initials: SL
authors.lastname: Archer
authors.forename: D
authors.initials: D
authors.lastname: Peterson
authors.forename: D P
authors.initials: DP
authors.lastname: Nelson
authors.forename: E G
authors.initials: EG
authors.lastname: DeMaster
authors.forename: B
authors.initials: B
authors.lastname: Kelly
authors.forename: J W
authors.initials: JW
authors.lastname: Eaton
authors.forename: E K
authors.initials: EK
authors.lastname: Weir
mesh_terms: D000818:Animals; D003676:Deferoxamine / Q000494:pharmacology; D005609:Free Radicals; D066298:In Vitro Techniques; D008081:Liposomes; D008297:Male; D010088:Oxidoreductases / Q000008:administration & dosage / Q000494:pharmacology*; D010100:Oxygen / Q000494:pharmacology*; D011652:Pulmonary Circulation / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000008:administration & dosage / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects*
chemical_list: D005609:Free Radicals; D008081:Liposomes; D012709:Serum Albumin; D010088:Oxidoreductases; D003676:Deferoxamine; D010100:Oxygen